Cargando…
NQO1 potentiates apoptosis evasion and upregulates XIAP via inhibiting proteasome-mediated degradation SIRT6 in hepatocellular carcinoma
BACKGROUND: Our previous study has demonstrated that NAD(P)H: quinone oxidoreductase 1 (NQO1) is significantly upregulated in human liver cancer where it potentiates the apoptosis evasion of liver cancer cell. However, the underlying mechanisms of the oncogenic function of NQO1 in HCC have not been...
Autores principales: | Zhou, Hong-Zhong, Zeng, Han-Qing, Yuan, Ding, Ren, Ji-Hua, Cheng, Sheng-Tao, Yu, Hai-Bo, Ren, Fang, Wang, Qing, Qin, Yi-Ping, Huang, Ai-Long, Chen, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915971/ https://www.ncbi.nlm.nih.gov/pubmed/31842909 http://dx.doi.org/10.1186/s12964-019-0491-7 |
Ejemplares similares
-
NQO1 inhibits proteasome-mediated degradation of HIF-1α
por: Oh, Eun-Taex, et al.
Publicado: (2016) -
XIAP inhibits mature Smac-induced apoptosis by degrading it through ubiquitination in NSCLC
por: Qin, Sida, et al.
Publicado: (2016) -
NQO1 Binds and Supports SIRT1 Function
por: Tsvetkov, Peter, et al.
Publicado: (2021) -
Inhibition of the ubiquitin-proteasome system by an NQO1-activatable compound
por: Giovannucci, Tatiana A., et al.
Publicado: (2021) -
Targeted Degradation of XIAP is Sufficient and Specific to Induce Apoptosis in MYCN-overexpressing High-risk Neuroblastoma
por: Choo, Zhang'E, et al.
Publicado: (2023)